Neurobiological Sequelae of the Passive or Voluntary Administration of the Synthetic Cannabinoid Receptor Agonist JWH-018
The use of synthetic cannabinoids receptor agonists (SCRAs) is growing among adults and adolescents, posing major medical and psychiatric risks. JWH-018 represents the reference compound of SCRA-containing products. Our studies were performed to evaluate the enduring consequences of repeated JWH-018...
Saved in:
| Main Author: | M.A. De Luca |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-12-01
|
| Series: | Emerging Trends in Drugs, Addictions, and Health |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2667118223000351 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
From JWH-018 to OXIZIDS: Structural Changes in Newly Emerged Synthetic Cannabinoids in the European Union from December 2008 to December 2021
by: R. Andrews, et al.
Published: (2024-12-01) -
5HT2A Receptors are Involved in the Pharmaco-Toxicological Effects of the Synthetic Cannabinoids JWH-018 and 5F-PB22: in Vivo Studies in Mice
by: G. Corli, et al.
Published: (2024-12-01) -
SCRAs with a “Brand” New Look: In Vitro Cannabinoid Activity Profiling of Generic Ban-Evading Brominated Synthetic Cannabinoid Receptor Agonists and their Analogs
by: M.H. Deventer, et al.
Published: (2024-12-01) -
Treatment with CB2 Agonist JWH-133 Reduces Histological Features Associated with Erectile Dysfunction in Hypercholesterolemic Mice
by: Rodrigo Araujo Fraga-Silva, et al.
Published: (2013-01-01) -
Synthetic Cannabinoid and Methadone Co-administration in Prolonging the QTc Interval
by: K.L. Rock, et al.
Published: (2024-12-01)